Exforge 5/80 mg
Exforge 5/80 mg is a medicine authorised by Swissmedic under authorisation number 57771. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 December 2006 and the authorisation is valid without a time limit. ATC code C09DB01 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 57771 |
|---|---|
| Name | Exforge 5/80 mg |
| Full name | Exforge 5/80 mg, Filmtabletten |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DB01 |
| First authorisation | 22 December 2006 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Exforge 5/80 mg, Filmtabletten | B | 22 December 2006 |
| 2 | Exforge 5/160 mg, Filmtabletten | B | 22 December 2006 |
| 3 | Exforge 10/160 mg, Filmtabletten | B | 22 December 2006 |
| 4 | Exforge 5/320 mg, Filmtabletten | B | 22 December 2008 |
| 5 | Exforge 10/320 mg, Filmtabletten | B | 22 December 2008 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 28 | Tablette(n) | C09DB01 | 02.07.2. | B |
| 4 | 98 | Tablette(n) | C09DB01 | 02.07.2. | B |
| 6 | 56 | Tablette(n) | C09DB01 | 02.07.2. | B |
| 8 | 28 | Tablette(n) | C09DB01 | 02.07.2. | B |
| 10 | 98 | Tablette(n) | C09DB01 | 02.07.2. | B |
| 12 | 56 | Tablette(n) | C09DB01 | 02.07.2. | B |
| 14 | 28 | Tablette(n) | C09DB01 | 02.07.2. | B |
| 16 | 98 | Tablette(n) | C09DB01 | 02.07.2. | B |
| 18 | 56 | Tablette(n) | C09DB01 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Exforge 5/80 mg authorised in Switzerland?
Yes. Exforge 5/80 mg is authorised by Swissmedic under authorisation number 57771, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Exforge 5/80 mg have?
Exforge 5/80 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Exforge 5/80 mg?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.